« Previous
Next »
Lung Cancer
Volume 69, Issue 1
, Pages
99-104
, July 2010
A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer
To access this article, please choose from the options below
☆ Our clinical trial registration numbers are UMIN000001751 and UMIN000001752.
PII: S0169-5002(09)00496-6
doi: 10.1016/j.lungcan.2009.09.012
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Lung Cancer
Volume 69, Issue 1
, Pages
99-104
, July 2010
